Reference
1. Anderson UD, Olsson MG, Kristensen KH, Åkerström B, Hansson SR.
Review: Biochemical markers to predict preeclampsia. Placenta. 2012;33
Suppl:S42-7.
2. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al.
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat
Med. 2006;12(6):642-9.
3. Paauw ND, Lely AT. Cardiovascular Sequels During and After
Preeclampsia. Adv Exp Med Biol. 2018;1065:455-70.
4. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia:
Pathophysiology, Challenges, and Perspectives. Circ Res.
2019;124(7):1094-112.
5. Özkara A, Kaya AE, Başbuğ A, Ökten SB, Doğan O, Çağlar M, et al.
Proteinuria in preeclampsia: is it important? Ginekol Pol.
2018;89(5):256-61.
6. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin,
Number 222. Obstet Gynecol. 2020;135(6):e237-e60.
7. Tryggvason K, Wartiovaara J. Molecular basis of glomerular
permselectivity. Curr Opin Nephrol Hypertens. 2001;10(4):543-9.
8. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria
in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4(1):39-45.
9. Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C,
Simon A, et al. Early urinary and plasma biomarkers for experimental
diabetic nephropathy. Clin Lab. 2012;58(7-8):659-71.
10. Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, et al.
Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross
sectional study. PLoS One. 2012;7(5):e36041.
11. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, et
al. Podocyte injury damages other podocytes. J Am Soc Nephrol.
2011;22(7):1275-85.
12. Hauser PV, Collino F, Bussolati B, Camussi G. Nephrin and
endothelial injury. Curr Opin Nephrol Hypertens. 2009;18(1):3-8.
13. Son GH, Kwon JY, Lee S, Park J, Kim YJ, Yun B, et al. Comparison of
serum and urinary nephrin levels between normal pregnancies and severe
preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):139-44.
14. Wang Y, Zhao S, Loyd S, Groome LJ. Increased urinary excretion of
nephrin, podocalyxin, and βig-h3 in women with preeclampsia. Am J
Physiol Renal Physiol. 2012;302(9):F1084-9.
15. Jung YJ, Cho HY, Cho S, Kim YH, Jeon JD, Kim YJ, et al. The Level of
Serum and Urinary Nephrin in Normal Pregnancy and Pregnancy with
Subsequent Preeclampsia. Yonsei Med J. 2017;58(2):401-6.
16. Garovic VD, Wagner SJ, Petrovic LM, Gray CE, Hall P, Sugimoto H, et
al. Glomerular expression of nephrin and synaptopodin, but not podocin,
is decreased in kidney sections from women with preeclampsia. Nephrol
Dial Transplant. 2007;22(4):1136-43.
17. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S,
et al. Hypertensive Disorders of Pregnancy: ISSHP Classification,
Diagnosis, and Management Recommendations for International Practice.
Hypertension. 2018;72(1):24-43.
18. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P,
et al. New gestational phase-specific cutoff values for the use of the
soluble fms-like tyrosine kinase-1/placental growth factor ratio as a
diagnostic test for preeclampsia. Hypertension. 2014;63(2):346-52.
19. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler
H, et al. The sFlt-1/PlGF ratio in different types of hypertensive
pregnancy disorders and its prognostic potential in preeclamptic
patients. Am J Obstet Gynecol. 2012;206(1):58.e1-8.
20. Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, Suzuki T, et al.
Acute and transient podocyte loss and proteinuria in preeclampsia.
Nephron Clin Pract. 2009;112(2):c65-70.
21. Garovic VD, Craici IM, Wagner SJ, White WM, Brost BC, Rose CH, et
al. Mass spectrometry as a novel method for detection of podocyturia in
pre-eclampsia. Nephrol Dial Transplant. 2013;28(6):1555-61.
22. Kandasamy Y, Smith R, Lumbers ER, Rudd D. Nephrin - a biomarker of
early glomerular injury. Biomark Res. 2014;2:21.
23. Zhai T, Furuta I, Akaishi R, Ishikawa S, Morikawa M, Yamada T, et
al. Alteration of podocyte phenotype in the urine of women with
preeclampsia. Sci Rep. 2016;6:24258.
24. Zhao S, Gu X, Groome LJ, Wang Y. Decreased nephrin and GLEPP-1, but
increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue
sections from women with preeclampsia. Reprod Sci. 2009;16(10):970-9.
25. Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S,
Benedetto C, et al. Preeclamptic sera induce nephrin shedding from
podocytes through endothelin-1 release by endothelial glomerular cells.
Am J Physiol Renal Physiol. 2008;294(5):F1185-94.
26. Son GH, Kim JH, Hwang JH, Kim YH, Park YW, Kwon JY. Urinary
excretion of nephrin in patients with severe preeclampsia. Urinary
nephrin in preeclampsia. Hypertens Pregnancy. 2011;30(4):408-13.
27. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al.
Circulating angiogenic factors and the risk of preeclampsia. N Engl J
Med. 2004;350(7):672-83.
28. Lynch AM, Murphy JR, Gibbs RS, Levine RJ, Giclas PC, Salmon JE, et
al. The interrelationship of complement-activation fragments and
angiogenesis-related factors in early pregnancy and their association
with pre-eclampsia. BJOG: An International Journal of Obstetrics &
Gynecology. 2010;117(4):456-62.
29. Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers
RW, et al. Redefining preeclampsia using placenta-derived biomarkers.
Hypertension. 2013;61(5):932-42.
30. Roberts JM, Bell MJ. If we know so much about preeclampsia, why
haven’t we cured the disease? J Reprod Immunol. 2013;99(1-2):1-9.
31. Myers JE, Kenny LC, McCowan LM, Chan EH, Dekker GA, Poston L, et al.
Angiogenic factors combined with clinical risk factors to predict
preterm pre-eclampsia in nulliparous women: a predictive test accuracy
study. BJOG: An International Journal of Obstetrics & Gynecology.
2013;120(10):1215-23.
32. Tarca AL, Romero R, Benshalom-Tirosh N, Than NG, Gudicha DW, Done B,
et al. The prediction of early preeclampsia: Results from a longitudinal
proteomics study. PLoS One. 2019;14(6):e0217273.
33. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestilä M,
Jalanko H, et al. Nephrin is specifically located at the slit diaphragm
of glomerular podocytes. Proceedings of the National Academy of
Sciences. 1999;96(14):7962.
34. Patrakka J, Tryggvason K. Nephrin–a unique structural and
signaling protein of the kidney filter. Trends Mol Med.
2007;13(9):396-403.
35. Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB.
Nephrin ectodomain engagement results in Src kinase activation, nephrin
phosphorylation, Nck recruitment, and actin polymerization. J Clin
Invest. 2006;116(5):1346-59.
36. Ohmori T, De S, Tanigawa S, Miike K, Islam M, Soga M, et al.
Impaired NEPHRIN localization in kidney organoids derived from nephrotic
patient iPS cells. Sci Rep. 2021;11(1):3982.
37. Ng DP, Tai BC, Tan E, Leong H, Nurbaya S, Lim XL, et al. Nephrinuria
associates with multiple renal traits in type 2 diabetes. Nephrol Dial
Transplant. 2011;26(8):2508-14.
Table 1. The baseline characteristics of study population